Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...

If there is one global issue that we have waited for change on, it’s cannabis legalization. Medical marijuana has appeared in ...

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx ...

Purchase of UK-based Discover Momenta and Momenta Newcastle ('Momenta') for undisclosed amountAcquisition will significantly increase Liva's reach and ...

This Valentine’s Day, break away from the norm and embrace the joy of self-love. Discover how to turn February 14 into a day ...